BioSpace News Archive

Early-Stage Bioerodible Sustained-Release Technologies Designed for the Treatment of Retinal Diseases

LivaNova PLC announced that Stacy Enxing Seng, a Venture Partner with Lightstone Ventures and former executive at several healthcare and medical technology companies, was elected by the Company’s shareholders to join its Board of Directors during its June 18 annual general meeting.

Canopy Growth Corporation is pleased to announce that the Company’s shareholders voted overwhelmingly in favour of the resolution approving the issuance of common shares of Canopy Growth and certain amendments to certain outstanding Company warrants in connection with the Company’s previously announced proposed acquisition of Acreage Holdings, Inc..

Cryoport, Inc. announced the pricing of its underwritten public offering of an aggregate of 3,750,000 newly issued shares of common stock at a price of $17.00 per share.

Prevail Therapeutics Inc. announced the pricing of its initial public offering of 7,353,000 shares of its common stock at a price to the public of $17.00 per share.

A reconfigurable “body-on-a-chip” model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organs, such as the heart and liver.

A team of researchers from Carnegie Mellon University, in collaboration with the University of Minnesota, has made a breakthrough in the field of noninvasive robotic device control.

Quadrant Biosciences Inc., a developer of epigenetic diagnostic technologies, has been awarded a $330,000 grant from the National Institutes of Health (NIH).

Combined cancer program at Joseph M. Sanzari Children’s Hospital and K. Hovnanian Children’s Hospital ranked #44 in the U.S. and Joseph M. Sanzari Children’s Hospital ranked #49 for Pediatric Neurology and Neurosurgery

Pelican BioThermal, the global name in temperature-controlled packaging, launched its new network station and service center in Dublin, Ireland with an official opening ceremony.